Jonathan I Osorio-mckenna, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 816 S 5th St, Montrose, CO 81401 Phone: 970-249-3322 Fax: 970-240-7976 |
Dr. Mindy Lynn Miller, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 19540 6565 Road, Montrose, CO 81403 Phone: 970-367-1414 Fax: 970-572-9641 |
Lindsay Leanne Meredith, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 816 S 5th St, Montrose, CO 81401 Phone: 970-249-3322 Fax: 970-240-7976 |
Dr. David P Olson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1804 E Pavilion Pl, Montrose, CO 81401 Phone: 970-249-6670 Fax: 970-252-1372 |
Dr. Joseph Adragna Iv, MD, MHA, MGH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 E. Niagara Road, Montrose, CO 81401 Phone: 970-497-4921 Fax: 855-855-4482 |
Abraham Kyung Ho Lee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 630 E Star Ct, Montrose, CO 81401 Phone: 970-240-0378 Fax: 970-240-3346 |
Dr. Jeffrey J Krebs, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 5 Hillcrest Plaza Way, Montrose, CO 81401 Phone: 970-249-9678 Fax: 970-249-1868 |
News Archive
Women who have difficulty getting pregnant often turn to in-vitro fertilization (IVF), but it doesn't always work. Now scientists are taking a new approach to improve the technique by studying the proteins that could help ready a uterus for an embryo to implant in its wall.
The $40 million expansion of The Cardiac Centers of Mercy & Unity Hospitals reaches a significant milestone this week with the opening of the most technologically advanced cardiovascular catheterization laboratories in Minnesota.
Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.
Today, Korlym (mifepristone) was approved by the U.S. Food and Drug Administration to control high blood sugar levels (hyperglycemia) in adults with endogenous Cushing's syndrome.
A team of Medical University of South Carolina Hollings Cancer Center researchers received a three-year, $1.2 million grant from the U.S. Department of Defens to test a potential therapeutic antibody that could block breast cancer growth with fewer side effects, opening up potential for future drug development.
› Verified 9 days ago